1. Therapeutic target identification and validation: the case of enzymes
In the therapeutic discovery phase, thousands of candidate molecules are analyzed to test their efficacy against a given target (drug screening). Of these, only several hundred will be retained for further preclinical development (optimization of synthesis, formulation (§ 3 and
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Therapeutic target identification and validation: the case of enzymes
Therapeutic target identification and validation: with cells
Bibliography
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Article included in this offer
"Drugs and pharmaceuticals"
(
131 articles
)
Updated and enriched with articles validated by our scientific committees
A set of exclusive tools to complement the resources
